$293 Million is the total value of Defender Capital, LLC.'s 35 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -1,271 | -100.0% | -0.07% | – |
| CSCO | Exit | CISCO SYS INC | $0 | – | -4,046 | -100.0% | -0.07% | – |
| DIS | Exit | WALT DISNEY CO | $0 | – | -2,013 | -100.0% | -0.08% | – |
| Exit | ENOVIS CORPORATION | $0 | – | -7,500 | -100.0% | -0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-07-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL CL B | 23 | Q2 2024 | 24.4% |
| DANAHER CORPORATION COM | 23 | Q2 2024 | 18.3% |
| STAAR SURGICAL CORPORATION | 23 | Q2 2024 | 20.2% |
| FORTIVE CORPORATION | 23 | Q2 2024 | 14.3% |
| MONSTER BEVERAGE CORPORATION | 23 | Q2 2024 | 17.3% |
| APPLE INC | 23 | Q2 2024 | 0.6% |
| AMAZON INC COM | 23 | Q2 2024 | 0.5% |
| VANGUARD SHORT TERM TREASURY ETF IV | 20 | Q2 2024 | 23.9% |
| LINEAGE CELL THERAPEUTICS INC | 20 | Q2 2024 | 4.8% |
| AXON ENTERPRISE INC | 19 | Q2 2024 | 5.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-07-29 |
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-01-23 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-18 |
| 13F-HR/A | 2023-05-16 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-07-26 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.